Related Experiment Video
Updated: Mar 27, 2026

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
The many pathways driving liver inflammation in MASH
Herbert Tilg1, Timon E Adolph1, Stefano Romeo2
1Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology & Metabolism, Medical University of Innsbruck, Innsbruck, Austria.
Metabolic dysfunction-associated steatotic liver disease (MASLD) affects one-third of the global population. New therapies targeting its complex inflammatory pathways show promise for improved clinical management.
Area of Science:
- Hepatology and metabolic disease research
Background:
- Metabolic dysfunction-associated steatotic liver disease (MASLD) is a global health concern, impacting one-third of the world's population.
- A significant portion of MASLD patients progress to metabolic dysfunction-associated steatohepatitis (MASH), increasing the risk of cirrhosis and liver cancer.
Purpose of the Study:
- To review the complex, multifactorial inflammatory mechanisms driving MASH development.
- To analyze the pleiotropic metabolic and anti-inflammatory effects of emerging MASH therapies.
Main Methods:
- Review of current scientific literature on MASLD and MASH pathogenesis.
- Analysis of polygenetic and multiomic risk scores for patient stratification.
- Evaluation of the pharmacological properties of novel MASH drug candidates.
Main Results:
- MASH pathogenesis involves parallel inflammatory hits, including hepatic lipotoxicity, gut dysbiosis, and diet-induced immune responses.
- Obesity-driven adipose tissue inflammation exacerbates MASH.
- Emerging MASH therapies demonstrate broad metabolic and anti-inflammatory actions.
Conclusions:
- Understanding the intricate inflammatory pathways in MASH is crucial for effective treatment.
- Current and upcoming MASH therapies possess multifaceted properties that are expected to significantly alter clinical practice.
Related Concept Videos
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

